Jun 2026 (Q2 FY26) — Aug 5, 2026
Ginkgo Q2 FY26 — Autonomous Labs Drive Strategic Shift and Cost Efficiency
Read the full callGinkgo (DNA) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Ginkgo earnings: last reported Wed, 5 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 20.2 | −48.5% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -290.5 | −141.8 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -46.7 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$11.76 +1.99% · +$0.23
Performance −16.5% 1Y
1Y: $14.09 on 14 Oct 2025 → $11.76. High $15.83 (15 Oct 2025), low $5.48 (30 Mar 2026).
- Previous close
- $11.53
- 52-week range
- $5.48 – $15.83
- One year
- −25.71%
Overview
- Symbol
- DNA
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Ginkgo earnings calls (DNA)
Financials
What the filings say
Net profit, year on year: +23% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 89 | 44 | 38 | 39 | 39 | 33 | 19 | 20 |
| Expenses | — | — | 119 | 97 | — | — | 91 | 79 |
| Operating profit | -55 | -104 | -81 | -58 | -90 | -71 | -71 | -59 |
| Operating margin | −62.0% | −236.3% | −211.8% | −148.6% | −231.8% | −211.9% | −366.5% | −290.5% |
| Interest | -9 | 31 | — | — | — | — | — | — |
| Profit before tax | -57 | -108 | -83 | -53 | -81 | -81 | -76 | -57 |
| Tax rate | 0.7% | 0.3% | −0.1% | 0.5% | 0.0% | 0.8% | 0.1% | −0.2% |
| Net profit | -56 | -108 | -91 | -60 | -81 | -81 | -83 | -47 |
| EPS ($ per share) | -1.08 | — | -1.68 | -1.10 | -1.45 | — | -1.39 | -0.75 |
| Line item | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Equity capital | — | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | — | -468 | -2,298 | -4,398 | -5,291 | -5,838 | -6,150 |
| Total liabilities | — | 205 | 504 | 803 | 568 | 661 | 611 |
| Fixed assets | — | 121 | 146 | 315 | 188 | 204 | 167 |
| Investments | — | — | — | — | — | 0 | 255 |
| Total assets | — | 675 | 2,071 | 2,539 | 1,665 | 1,377 | 1,120 |
| Line item | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -45 | -136 | -254 | -252 | -295 | -320 | -171 |
| Cash from investing | -75 | -67 | -73 | -67 | -81 | -62 | -240 |
| Cash from financing | 410 | 90 | 1,534 | 95 | -3 | -2 | 18 |
| Net cash flow | 291 | -113 | 1,207 | -223 | -380 | -384 | -393 |
| Capital expenditure | -22 | -58 | -57 | -52 | -41 | -63 | -8 |
| Free cash flow | -67 | -194 | -310 | -304 | -336 | -382 | -179 |
Insider filings
47 filings between Oct 16, 2025 and Oct 5, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$3.67M
19 sales by 5 insiders
Compensation
not trading decisions- 28
- Option exercise — converted options into shares
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Kelly Jason R | — | $1.37M | Apr 9, 2026 |
| Shetty Reshma P. | — | $977.6K | Apr 10, 2026 |
| Canton Barry | — | $977.6K | Apr 10, 2026 |
| Coen Steven P. | — | $300.1K | Oct 5, 2026 |
| HENRY CHRISTIAN O | — | $35.4K | Sep 15, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 5, 2026 | Coen Steven P. See remarks | Sale | 2,403 | $36.0K |
| Sep 15, 2026 | HENRY CHRISTIAN O Director | Sale | 5,000 | $35.4K |
| Aug 24, 2026 | Coen Steven P. See remarks | Sale | 330 | $2.3K |
| Aug 21, 2026 | Coen Steven P. See remarks | Option exercise | 156 | — |
| Aug 21, 2026 | Coen Steven P. See remarks | Option exercise | 587 | — |
| Jul 17, 2026 | Coen Steven P. See remarks | Sale | 752 | $5.9K |
| Jul 16, 2026 | Coen Steven P. See remarks | Option exercise | 1,174 | — |
| Jul 16, 2026 | Coen Steven P. See remarks | Option exercise | 312 | — |
| May 22, 2026 | Coen Steven P. See remarks | Sale | 307 | $2.6K |
| May 21, 2026 | Coen Steven P. See remarks | Option exercise | 587 | — |
| May 21, 2026 | Coen Steven P. See remarks | Option exercise | 156 | — |
| Apr 17, 2026 | Coen Steven P. See remarks | Sale | 324 | $2.6K |
| Apr 16, 2026 | Coen Steven P. See remarks | Option exercise | 156 | — |
| Apr 16, 2026 | Coen Steven P. See remarks | Option exercise | 587 | — |
| Apr 13, 2026 | Coen Steven P. See remarks | Sale | 33,171 | $212.8K |
| Apr 10, 2026 | Coen Steven P. See remarks | Option exercise | 45,553 | — |
| Apr 10, 2026 | Coen Steven P. See remarks | Option exercise | 28,368 | — |
| Apr 10, 2026 | Canton Barry 10% owner | Sale | 124,727 | $802.5K |
| Apr 10, 2026 | Shetty Reshma P. See remarks | Sale | 124,727 | $802.5K |
| Apr 9, 2026 | Shetty Reshma P. See remarks | Option exercise | 251,786 | — |
| Apr 9, 2026 | Canton Barry 10% owner | Option exercise | 251,786 | — |
| Apr 9, 2026 | Canton Barry 10% owner | Sale | 13,116 | $83.9K |
| Apr 9, 2026 | Kelly Jason R See remarks | Sale | 109,767 | $702.2K |
| Apr 9, 2026 | Shetty Reshma P. See remarks | Sale | 13,116 | $83.9K |
| Apr 8, 2026 | Shetty Reshma P. See remarks | Sale | 13,155 | $91.2K |
| Apr 8, 2026 | Shetty Reshma P. See remarks | Option exercise | 27,738 | — |
| Apr 8, 2026 | Canton Barry 10% owner | Sale | 13,155 | $91.2K |
| Apr 8, 2026 | Canton Barry 10% owner | Option exercise | 27,738 | — |
| Apr 8, 2026 | Kelly Jason R See remarks | Sale | 97,015 | $672.3K |
| Apr 8, 2026 | Kelly Jason R See remarks | Option exercise | 212,949 | — |
| Apr 7, 2026 | Shetty Reshma P. See remarks | Option exercise | 27,738 | — |
| Apr 7, 2026 | Canton Barry 10% owner | Option exercise | 27,738 | — |
| Apr 7, 2026 | Kelly Jason R See remarks | Option exercise | 212,949 | — |
| Mar 16, 2026 | Coen Steven P. See remarks | Sale | 708 | $4.8K |
| Mar 13, 2026 | Coen Steven P. See remarks | Option exercise | 1,174 | — |
| Mar 13, 2026 | Coen Steven P. See remarks | Option exercise | 312 | — |
| Jan 20, 2026 | Coen Steven P. See remarks | Sale | 972 | $8.7K |
| Jan 16, 2026 | Coen Steven P. See remarks | Option exercise | 587 | — |
| Jan 16, 2026 | Coen Steven P. See remarks | Option exercise | 1,062 | — |
| Jan 16, 2026 | Coen Steven P. See remarks | Option exercise | 156 | — |
| Dec 15, 2025 | Coen Steven P. See remarks | Sale | 736 | $6.5K |
| Dec 12, 2025 | Coen Steven P. See remarks | Option exercise | 1,174 | — |
| Dec 12, 2025 | Coen Steven P. See remarks | Option exercise | 312 | — |
| Oct 17, 2025 | Coen Steven P. See remarks | Sale | 1,312 | $17.9K |
| Oct 16, 2025 | Coen Steven P. See remarks | Option exercise | 1,061 | — |
| Oct 16, 2025 | Coen Steven P. See remarks | Option exercise | 312 | — |
| Oct 16, 2025 | Coen Steven P. See remarks | Option exercise | 1,174 | — |
| Oct 1, 2025 | Coen Steven P. See remarks | Sale | 5,609 | $84.1K |
| Sep 9, 2025 | HENRY CHRISTIAN O Director | Sale | 10,000 | $110.6K |
| Sep 8, 2025 | HENRY CHRISTIAN O Director | Sale | 10,000 | $109.2K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Ginkgo Bioworks Holdings, Inc.
Free account. Everything above stays public.
Write why you follow Ginkgo Bioworks Holdings, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading